Cancer Drug Price Rises 1,400% With No Generic to Challenge It

Since 2013, the price of a 40-year-old, off-patent cancer drug in the U.S. has risen 1,400%, putting the life-extending medicine out of reach for some patients.

from WSJ.com: US Business http://ift.tt/2Bzcc2m
via IFTTT